ResearcherShanghai Medical College of Fudan UniversityNo recent work listed
Ye Zeng
Matched on ORCID iD 0000-0003-1207-6486; OpenAlex author ID A5101727201. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: 3 papers
Papers 4
- SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2020.11.023↗
- FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. Co-author DOI 10.1016/j.redox.2020.101807↗
- MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-0414↗
- FGFBP1, a downstream target of the FBW7/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer. Co-author PMID 31911852↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaowu Xu · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Qiangsheng Hu · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Wenyan Xu · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Wensheng Liu · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Xianjun Yu · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Shunrong Ji · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Yi Qin · 4 shared papers, 2019–2021 · strength 0.43
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Qifeng Zhuo · 3 shared papers, 2021 · strength 0.34
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. DOI 10.1016/j.redox.2020.101807↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Zheng Zhang · 3 shared papers, 2019–2021 · strength 0.31
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Paper FGFBP1, a downstream target of the FBW7/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer. PMID 31911852↗
- Mengqi Liu · 3 shared papers, 2019–2021 · strength 0.31
- Paper SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer. DOI 10.1016/j.canlet.2020.11.023↗
- Paper MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Gly… DOI 10.1158/0008-5472.can-20-0414↗
- Paper FGFBP1, a downstream target of the FBW7/c-Myc axis, promotes cell proliferation and migration in pancreatic cancer. PMID 31911852↗
- Zheng Zhang · 1 shared paper, 2021 · strength 0.12
- Xiuhui Shi · 1 shared paper, 2021 · strength 0.10
- Zhijun Zhou · 1 shared paper, 2021 · strength 0.10
- Jingxuan Yang · 1 shared paper, 2021 · strength 0.10
- Qiqing Sun · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.